Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-03-17FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for risperidone by Ajanta Pharma USA Inc., expanding its regulatory clearance for additional indicat…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: eVAluatIon of OLanzapine TreatmEnT
A completed clinical trial evaluating olanzapine treatment in bipolar disorder and schizophrenia.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: How Reducing Anxiety in Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating anxiety reduction in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Lurasidone Extended Use Study [Phase 3]
This document reports the completion of a Phase 3 extended-use trial of lurasidone for schizophrenia and bipolar disorder, with results post…
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Auditory Verbal Hallucinations in Schizophrenia
The document notes the completion of a clinical trial investigating auditory verbal hallucinations in schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia [Phase 1]
Phase 1 safety and tolerability update for Lu AF35700 in schizophrenia patients following repeated dosing.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167 [Phase 1]
Phase 1 pharmacokinetic study evaluating various modified-release tablet formulations of Lu AF11167; the trial has completed in participants…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Bioavailability of LY03004 and Risperdal® Consta® [Phase 1]
Phase 1 study evaluating the bioavailability of LY03004 relative to Risperdal Consta (paliperidone palmitate) has been completed. The trial …
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders [EARLY_Phase 1]
An early Phase 1 trial evaluating a dopamine D1 receptor agonist for cognitive enhancement in schizophrenia and schizoaffective disorder has…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: Metacognitive Training in Schizophrenia [NA]
A completed clinical trial evaluating metacognitive training for schizophrenia, including delusions, is reported. The study was sponsored by…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: The Effects of Rimonabant, on Weight and Metabolic Risk Factors [Phase 2]
Phase 2 trial investigating the effects of rimonabant on weight and metabolic risk factors; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2015-02-24Clinical Trial Update: Pharmacokinetic Study of MIN-101 in Healthy Subjects [Phase 1]
Minerva Neurosciences completed a Phase 1 pharmacokinetic study of MIN-101 in healthy subjects, outlining basic PK parameters.
-
FDA approval · 2015-02-20FDA Approved: OLANZAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic olanzapine (oral) under ANDA203044. It covers indications for schizophrenia and bipo…
-
CLINICAL_TRIALS trial_result · 2015-02-19Clinical Trial Update: Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of multiple doses of ITI-214 in healthy adults and in adults with stable schizophre…
-
CLINICAL_TRIALS research · 2015-02-19Clinical Trial Update: Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems [NA]
A clinical trial update examining rehabilitation and quality-of-life outcomes for people with longer-term mental health problems living in r…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics [Phase 3]
Phase 3 trial comparing injectable paliperidone palmitate with oral antipsychotics for relapse prevention in schizophrenia; the study is com…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Omega-3 Fatty Acids Efficacy in First-episode of Schizophrenia [Phase 4]
A Phase 4 clinical trial update evaluating the efficacy of omega-3 fatty acids in individuals with first-episode schizophrenia; current stat…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of Lu AF11167 after repeated dosing in patients with schizophrenia; the study has c…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia [NA]
This clinical trial update notes the completion of a study examining how repetitive transcranial magnetic stimulation affects serum brain-de…
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia [Phase 3]
Phase 3 trial update reports results for aripiprazole intramuscular depot (OPC-14597 / Lu AF41155) in the acute treatment of adults with sch…
-
CLINICAL_TRIALS research · 2015-02-05Clinical Trial Update: Exploration of Neural Bases in Social Cognition [NA]
This clinical trial update describes an ongoing study from University Hospital, Caen investigating the neural bases of social cognition in s…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Clinical Estradiol Trial in Women With Schizophrenia [Phase 2]
A Phase 2 clinical trial of estradiol in women with schizophrenia has completed.
-
CLINICAL_TRIALS research · 2015-02-04Clinical Trial Update: Evaluation of Social Skills Intervention on Cognitive Function in Schizophrenia [NA]
Clinical trial update on evaluating a social skills intervention for improving cognitive function in people with schizophrenia; current stat…
-
FDA approval · 2015-02-04FDA Approved: ZIPRASIDONE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Ziprasidone from Chartwell RX, LLC, enabling a generic version of the antipsychotic to be ma…
-
CLINICAL_TRIALS trial_result · 2015-01-30Clinical Trial Update: Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial exploring selective estrogen receptor modulators as a potential treatment for psychotic symptoms in schizophrenia; th…